Eirgenix Receives Approval from Japan's PMDA
TAIPEI, Feb. 14, 2020 /PRNewswire-AsiaNet/ -- EirGenix's World-Class Biopharmaceutical Manufacturing Facility Becomes the First of Its Kind in Taiwan to Receive Approval EirGenix, Inc. (6589, TT) had undertaken the transfer of drug substance manufacturing of a marketed drug from a Japanes...
Authors: LATEST ASIANET NEWS RELEASES